Analyst Ratings for Centessa Pharmaceuticals (CNTA)

CNTA Rating Summary

CNTA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CNTA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $38.00 (+101.1%) * Over Last 12-Mos
Rating Score: 10 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/22/2021 Goldman Sachs Salveen Richter New Coverage Buy
(N/A)
42.00
(N/A)
24.91
(18.90)
-24.13% Details
6/22/2021 Morgan Stanley Matthew Harrison New Coverage Overweight
(N/A)
37.00
(N/A)
24.91
(18.90)
-24.13% Details
Like CNTA Ratings? Also take a look at C

CNTA Ratings News